JOURNAL ARTICLE

GPCR-targeted drug discovery

Xin Xie

Year: 2019 Journal:   Planta Medica   Publisher: Thieme Medical Publishers (Germany)

Abstract

G-protein coupled receptors (GPCRs), also known as 7 transmembrane receptors, are the largest family of cell surface receptors. They are involved in a wide variety of physiological and pathological processes and are the largest family of druggable targets. Our group is interested in the biological functions of GPCRs and their roles in major diseases including autoimmune disease, neurodegenerative diseases, metabolic diseases and etc. In addition to the mechanism study, we also screen and develop drugs targeting GPCRs. Natural compounds may exert their effect by targeting GPCRs.

Keywords:
Druggability G protein-coupled receptor Drug discovery Receptor Computational biology Biology Rhodopsin-like receptors Drug Bioinformatics Mechanism (biology) Medicine Neuroscience Pharmacology Genetics Gene Metabotropic receptor

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.13
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Receptor Mechanisms and Signaling
Life Sciences →  Biochemistry, Genetics and Molecular Biology →  Molecular Biology
Monoclonal and Polyclonal Antibodies Research
Health Sciences →  Medicine →  Radiology, Nuclear Medicine and Imaging

Related Documents

JOURNAL ARTICLE

A perspective on more effective GPCR-targeted drug discovery efforts

Annette Gilchrist

Journal:   Expert Opinion on Drug Discovery Year: 2008 Vol: 3 (4)Pages: 375-389
BOOK

Computational Methods for GPCR Drug Discovery

Alexander Heifetz

Methods in molecular biology Year: 2017
JOURNAL ARTICLE

GPCR Insights Brighten Drug Discovery Outlook

Ken Doyle

Journal:   Genetic Engineering & Biotechnology News Year: 2014 Vol: 34 (8)Pages: 1, 12-14
© 2026 ScienceGate Book Chapters — All rights reserved.